Affiliation:
1. the Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Centre
2. the Sixth Affiliated Hospital of Sun Yat-sen University
3. Dazhou Vocational and Technical College
4. Dazhou Central Hospital
Abstract
Abstract
BACKGROUND AND AIMS: Whether preoperative serum carbohydrate antigen (CA) 72-4 is an independent predictor of outcome and whether has an interaction between CA72-4 and the impact of carcinoembryonic antigen (CEA) on colorectal cancer (CRC) patients' risk of recurrence is still unknown.
PATIENTS AND METHODS: Patients with pathologically confirmed stage I-III colorectal adenocarcinoma who received direct radical resection at 2 hospitals from 2008 to 2017 were collected. According to the levels of CEA and CA72-4 before operation, the patients were divided into 4 groups: Group A with normal CEA and CA72-4 levels preoperatively (CEA≤5.0 ng/mL,CA72-4≤6.9 U/mL, n=952) ;Group B had normal preoperative CEA but high CA72-4 levels (CEA≤5.0 ng/mL,CA72-4>6.9 U/mL, n=217) ;Group C had elevated preoperative CEA but normal CA72-4 (CEA>5.0 ng/mL,≤6.9 U/mL, n=574) ;Group D had both elevated preoperative CEA and CA72-4 (CEA>5.0 ng/mL, CA72-4>6.9 U/mL, n=182). The Kaplan-Meier survival curve and a COX regression model was used to estimate the correlation between preoperative CA72-4 and overall survival (OS) and recurrence-free survival (RFS).
Results: A total of 3,651 patients (52.7%) are included in this study. Median age (IQR) : 60.0 (50.0, 68.0) years; Mean body mass index (BMI) (SD) : 22.718(3.256) kg/m2. Compared with normal CA 72-4 (≤6.9 U/mL, n=3252), patients with increased CA 72-4 (>6.9U/mL, n=399) had higher OS(HR:1.4;95% CI, 1.07-1.83; P = 0.0072). In Cox multivariate analysis, increased preoperative CEA and CA72-4 were associated with shorter RFS(HR:1.69;95% CI, 1.23- 2.32; P = 0.001) and OS (HR, 2.92;95% CI, 2.14-3.98; P< 0.001). However, patients with normal preoperative CEA, no matter if CA72-4 is increased or normal, were not associated with RFS and OS shortening, while patients with high CEA but normal CA72-4 were only associated with OS(HR:1.82;95% CI, 1.42-2.33; P <0.001).
Conclusion: CA72-4 is an independent predictor of outcome for patients with elevated preoperative CEA. The influence of preoperative CA72-4 level on prognosis is different under different CEA stratification. It is necessary to combine CA72-4 with CEA to predict the prognosis of patients.
Publisher
Research Square Platform LLC
Reference24 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer JC. 2016 Jan-Feb;66(1):7–30. Epub 2016 Jan 7. PMID: 26742998. https://doi.org/10.3322/caac.21332
2. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths;Brawley O,2013
3. Liu L, Xu HX, Wang WQ, Wu CT, Xiang JF, Liu C, Long J, Xu J, Fu de L, Ni QX, Houchen CW, Postier RG, Li M. Y u XJ. Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. Oncotarget. 2016 Feb 2;7(5):5943-56. 6819. PMID: 26745601; PMCID: PMC4868732. https://doi.org/10.18632/oncotarget.6819.
4. Cancer Antigen 72 – 4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries[J];Mariampillai AI;Anticancer Res,2017
5. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population;Chen XZ;Mol Biol Rep,2012